Cahaba Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Cahaba Wealth Management's AMGN Position: Q2 2026 in Review
Cahaba Wealth Management reduced its Amgen (AMGN) stake by 0.94% in Q2 2026, selling an estimated $2.05K and leaving 631 shares worth $229K. The position accounts for 0.01% of the portfolio, ranked #155.
Cahaba Wealth Management first reported a position in AMGN in Q3 2021 and has held it in 20 quarters since. The position peaked at $531K in Q4 2021. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Cahaba Wealth Management held 631 shares of Amgen worth $229K as of Q2 2026.
- Cahaba Wealth Management sold 6 Amgen shares in Q2 2026, an estimated $2.05K.
- Amgen made up 0.01% of Cahaba Wealth Management's portfolio in Q2 2026, its #155 holding.
- Cahaba Wealth Management first reported a position in Amgen in Q3 2021 and has held it in 20 quarters since.
- Cahaba Wealth Management's Amgen position peaked at $531K in Q4 2021.
- 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Cahaba Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.